Assessment of the clinical perception, quality of life and satisfaction of patients with severe congenital haemophilia A without inhibitor after 1 year of emicizumab therapy
Sign Up to like & getrecommendations! Published in 2023 at "Haemophilia"
DOI: 10.1111/hae.14755
Abstract: Since the approval by the EMA of emicizumab for the care of severe haemophilia A without inhibitor, most of the patients of our haemophilia treatment centre started this new treatment. Thanks to the setting of… read more here.
Keywords: without inhibitor; clinical perception; haemophilia without; emicizumab ... See more keywords